Get the Stockscreener App
56.44
0.06%
0.035
State Street Spdr S P Pharmaceuticals Etf stock is traded at $56.44, with a volume of 7,235.
It is up +0.06% in the last 24 hours and up +10.85% over the past month.
See More
Previous Close:
$56.40
Open:
$56.66
24h Volume:
7,235
Relative Volume:
0.13
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.82%
1M Performance:
+10.85%
6M Performance:
+34.18%
1Y Performance:
+26.71%
1-Day Range:
$56.31
$56.71
1-Week Range:
$55.33
$57.24
52-Week Range:
$35.22
$57.24
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
56.65 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.72 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
685.19 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
614.33 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock - Seeking Alpha
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Should You Invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - Yahoo Finance
3 Undervalued ETFs to Buy Before 2026 - Yahoo Finance
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? - Yahoo Finance
Should you invest in the First Trust Health Care AlphaDEX ETF (FXH)? - MSN
Pharma ETF (XPH) hits a new 52-week high - MSN
Pfizer partners with YaoPharma to develop weight management drug - MSN
Pharma ETF (XPH) Hits a New 52-Week High - Zacks Investment Research
Should You Invest in the State Street SPDR S&P Software & Services ETF (XSW)? - Yahoo Finance
Is State Street SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? - Yahoo Finance
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
State Street SPDR S&P 1500 Momentum Tilt ETF Holdings - Quiver Quantitative
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
Best-Performing ETFs of November - TradingView
Should State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar? - Yahoo Finance
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - MSN
SPYM: S&P 500 Monthly Dashboard For December - Seeking Alpha
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - MSN
Should State Street SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar? - sharewise.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation (NYSEARCA:IHE) - Seeking Alpha
Here's How Many Shares of the SPDR S&P Dividend ETF (SDY) You'd Need for $500 in Yearly Dividends - AOL.com
Should State Street SPDR Portfolio S&P 500 ETF (SPYM) Be on Your Investing Radar? - Yahoo Finance
How Is Eli Lilly’s Stock Performance Compared to Other Pharmaceuticals? - inkl
Small Caps, Pharma Surge, While Nvidia, AMD TumbleState Street Health Care Select Sector SPDR ETF (ARCA:XLV) - Benzinga
State Street SPDR S&P Pharmaceuticals ETF Holdings - Quiver Quantitative
Best-Performing ETFs of Last Week: Healthcare Rules - TradingView
Should State Street SPDR Portfolio S&P 500 Growth ETF (SPYG) Be on Your Investing Radar? - Yahoo Finance
State Street SPDR S&P 1500 Value Tilt ETF Holdings - Quiver Quantitative
Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN
LVLNState Street SPDR S&P Leveraged Loan ETF Stock Price and Quote - Finviz
LVLN ETF Holdings List — AMEX:LVLN - TradingView
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Biopharmaceutical stocks performed strongly against the market trend, bolstered by industry mergers and acquisitions as well as favorable policy developments. - 富途牛牛
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Traders Eye Nvidia Earnings And Fed Minutes In A Busy Morning - Finimize
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MSN
Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? - Benzinga
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight - Benzinga
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - sharewise.com
SLYV: Unconvincing Small Cap ETF (NYSEARCA:SLYV) - Seeking Alpha
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):